EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY 4.0

Updates in the 2025 AHA/ACC Hypertension Guideline

Carly Brown, Donald Clark, Daniel W Jones

Current Hypertension Reports · 17.03.2026 · 28 (1)

DOI: 10.1007/s11906-026-01372-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Hypertension Reports, online erschienen am 17.03.2026. Verfasst von Carly Brown und 2 weiteren Autor:innen. Beteiligte Einrichtung: IMPACT Center for Pharmacy Transformation, University of Mississippi School of Pharmacy, Jackson, MS, USA. Hauptthemen laut MEDLINE: Hypertension, Practice Guidelines as Topic, Antihypertensive Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose of Review Hypertension remains a leading cause of cardiovascular morbidity and mortality in the United States. The 2025 American Heart Association (AHA)/American College of Cardiology (ACC) Guideline for the Management of High Blood Pressure in Adults provides the first major update since 2017. It reveals new evidence in the diagnosis, risk assessment, and treatment of hypertension. This review summarizes key updates, contrasts them with prior recommendations, and discusses implications for clinical practice. Recent Findings The 2025 AHA/ACC Hypertension Guideline introduces several major updates that reshape risk assessment, diagnosis, and treatment strategy. Adoption of the PREVENT risk calculator replaces the pooled cohort equations, improving cardiovascular risk estimation by incorporating renal function, statin use, and social drivers of health. Screening for primary aldosteronism is expanded to all patients with stage 2 or resistant hypertension, addressing underdiagnosis of this secondary cause. Renal denervation is introduced as an adjunctive option for select patients with resistant hypertension. The guideline also provides expanded recommendations for special populations, including those with chronic kidney disease, diabetes, pregnancy, and neurologic disorders. Enhanced emphasis on home blood pressure monitoring, lifestyle modification, and team-based care highlights the growing importance of patient engagement and coordinated care. Summary The 2025 AHA/ACC Hypertension Guideline marks a pivotal shift toward risk-based, patient-centered hypertension management. It reinforces the need for tailored strategies that bridge clinical practice and population health. Effective implementation will depend on interdisciplinary collaboration and equitable access to preventative and therapeutic resources.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionPractice Guidelines as TopicAntihypertensive AgentsHumansUnited StatesAmerican Heart AssociationRisk Assessment

Stichwörter der Autor:innen

AHA/ACC 2025 guidelineCardiovascular risk assessmentHypertension managementPatient-centered careResistant hypertension

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • IMPACT Center for Pharmacy Transformation, University of Mississippi School of Pharmacy, Jackson, MS, USA.
  • Department of Medicine, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS, 39216, USA.
  • Department of Medicine, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS, 39216, USA. djones@umc.edu.

Zitieren

APA

Brown, C., Clark, D., & Jones, D. W. (2026). Updates in the 2025 AHA/ACC Hypertension Guideline. Current Hypertension Reports, 28(1). https://doi.org/10.1007/s11906-026-01372-9

Vancouver

Brown C, Clark D, Jones DW. Updates in the 2025 AHA/ACC Hypertension Guideline. Current Hypertension Reports. 2026;28(1). doi:10.1007/s11906-026-01372-9

BibTeX
@article{Brown2026,
  author = {Brown, Carly and Clark, Donald and Jones, Daniel W},
  title = {Updates in the 2025 AHA/ACC Hypertension Guideline},
  journal = {Current Hypertension Reports},
  year = {2026},
  volume = {28},
  number = {1},
  doi = {10.1007/s11906-026-01372-9}
}
Kostenlos starten →